On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Watch: Beyond the EEOC - the Widening Divide in Disparate Impact Enforcement - Employment Law This Week
- The Death of Disparate Impact? What Recent DOJ Guidance Signals to Employers
- Watch: The NLRB Is No Longer Independent—What Employers Need to Know - Employment Law This Week
- Defunding DEI Hits a Legal Wall: Courts Shield Federal Funding Recipients from Biased Artificial Intelligence (AI) Overreach
- New York Legislation Watch: Five Bills Employers Should Have on Their Radar